A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients. (1st November 2016) - Chen, A.C.; Martin, A.J.; Dalziell, R.A.; McKenzie, C.A.; Lowe, P.M.; Eris, J.M.; Scolyer, R.A.; Dhillon, H.M.; Vardy, J.L.; Bielski, V.A.; Halliday, G.M.; Damian, D.L.